• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Eli Lilly to buy AurKa Pharma financialexpress
    May 21, 2018
    Eli Lilly and Company has signed an agreement to acquire AurKa Pharma, established by TVM Capital Life Science to develop oncology compound AK-01, an Aurora kinase A inhibitor that was originally discovered at Lilly.
  • Lilly to acquire AurKa Pharma biospectrumasia
    May 16, 2018
    Acquisition Expands Lilly Oncology Pipeline with Early-Phase Asset Being Studied in Multiple Tumor Types

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service